II-VI Incorporated
COHR
$426.89
+17.63%
Coherent Corp. is a vertically integrated manufacturing company that develops, manufactures, and markets lasers, transceivers, and other optical and optoelectronic devices, modules, and systems, as well as engineered materials, serving the communications, industrial, instrumentation, and electronics markets. The company is a significant player in the photonics and compound semiconductor industry, operating through its Datacenter Communications and Industrial segments. The current investor narrative is heavily focused on the company's positioning as a critical 'picks and shovels' beneficiary of the accelerating AI infrastructure buildout, as evidenced by recent news highlighting massive AI-related orders and a sharp rotation into related hardware stocks, which has fueled a dramatic re-rating of the stock.…
COHR
II-VI Incorporated
$426.89
Related headlines
Investment Opinion: Should I buy COHR Today?
Rating: Hold. The core thesis is that COHR's powerful AI-driven growth story is compelling but is fully—if not excessively—priced in after a 354% rally, creating asymmetric risk/reward skewed to the downside for new capital at current levels.
Supporting evidence includes the accelerating 17.52% YoY revenue growth and strong quarterly operating margin of 11.80%, which validate the business momentum. However, the extreme trailing P/E of 279.75x and forward P/E of 44.65x represent a massive premium to the hardware sector. The stock trades at 87% of its 52-week high, indicating limited near-term upside to technical resistance at $413. Furthermore, the persistent negative free cash flow and low ROE of 0.61% underscore that financial quality lags the growth narrative.
The thesis would upgrade to Buy if the forward P/E compresses below 30x on a market pullback without damage to the growth story, or if the company reports consecutive quarters of positive free cash flow. It would downgrade to Sell if quarterly revenue growth decelerates below 10% or if operating margins contract significantly. Relative to its own history and sector peers, the stock is overvalued, as the current price implies perfection in executing a multi-year AI growth trajectory.
Sign up to view all
COHR 12-Month Price Forecast
The AI assessment is neutral based on a clash between powerful fundamental momentum and extreme valuation. The growth trajectory, evidenced by 17.52% revenue acceleration and a swing to profitability, is undeniable and tied to a durable megatrend. However, the forward P/E of 44.65x prices in years of flawless execution, and the stock's 354% run-up and high beta make it vulnerable to any disappointment. The stance would upgrade to bullish on a material pullback (toward $300) that improves the risk/reward, or if FCF turns positive. It would turn bearish if revenue growth decelerates below 10%, signaling a narrative break.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on II-VI Incorporated's 12-month outlook, with a consensus price target around $554.96 and implied upside of +30.0% versus the current price.
Average Target
$554.96
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$342 - $555
Analyst target range
Analyst coverage for COHR appears limited, with only 5 analysts providing estimates according to the provided data, and no explicit buy/hold/sell distribution or average price target is given in the analyst data block. The institutional ratings list shows recent actions from several major firms, all maintaining positive stances: Rosenblatt, Stifel, and Needham have 'Buy' ratings, while Barclays and JP Morgan have 'Overweight' ratings, and Morgan Stanley maintains an 'Equal Weight'. This pattern indicates a bullish to neutral consensus among covering institutions, with no recent downgrades. The absence of a quantified average target price and implied upside/downside in the data means the consensus sentiment is qualitatively positive but lacks a specific price anchor. Without a provided target price range, the signal strength is assessed through the consistency of recent institutional actions. The data shows a series of reiterations of positive ratings throughout Q1 2026, with no downgrades, suggesting analysts remain confident in the story despite the stock's massive run-up. A high target price would assume continued multiple expansion, market share gains in AI-driven markets, and successful execution on growth initiatives. A low target would factor in potential cyclical downturns, competitive pressures, or failure to convert revenue growth into sustained profitability and cash flow. The limited number of analysts (5) covering the stock, despite its large market cap, may indicate it is still gaining broader institutional recognition, which can lead to higher volatility and less efficient price discovery compared to more widely covered peers.
Bulls vs Bears: COHR Investment Factors
The bull case for COHR is compelling, driven by accelerating revenue growth tied to the AI infrastructure buildout, a powerful earnings turnaround, and strong institutional conviction. However, the bear case presents formidable risks, primarily centered on an extreme valuation that prices in flawless execution and a persistent lack of free cash flow. Currently, the bullish evidence on growth and momentum is stronger, but the investment debate hinges on a single critical tension: whether the company's explosive top-line growth can sustainably translate into robust profitability and positive cash flow fast enough to justify its sky-high valuation. A failure on this front would trigger a severe derating.
Bullish
- Accelerating AI-Driven Revenue Growth: Q2 2026 revenue grew 17.52% YoY to $1.686B, marking an acceleration from prior quarters. This growth is central to the 'picks and shovels' AI infrastructure thesis, as evidenced by recent news highlighting massive AI-related orders fueling a rotation into hardware stocks.
- Powerful Earnings Turnaround: The company swung from a net loss of -$95.6M in Q4 2025 to a net income of $147M in Q2 2026. This dramatic improvement signals strong operating leverage and a successful execution of its growth strategy, with quarterly operating margin reaching 11.80%.
- Strong Institutional & Analyst Sentiment: Recent institutional ratings from Rosenblatt, Stifel, and Needham are 'Buy', with Barclays and JP Morgan at 'Overweight'. This consistent bullish stance, despite a 354.56% one-year gain, indicates continued confidence in the company's strategic positioning.
- Exceptional Technical Momentum: The stock is up 354.56% over the past year and 39.60% over three months, significantly outperforming the S&P 500. It trades at 87% of its 52-week high ($413), demonstrating sustained bullish momentum and strong relative strength of 29.32 vs. the market.
Bearish
- Extreme Valuation Premium: The trailing P/E of 279.75x and forward P/E of 44.65x are far above typical hardware industry averages. This extreme premium, trading near its own historical highs, leaves no room for error and poses a severe risk of multiple contraction if growth falters.
- Persistent Negative Free Cash Flow: TTM free cash flow is negative $103.6M, and the latest quarter showed modest operating cash flow of $57.9M. This indicates the company is consuming cash to fund operations and growth, creating dependence on external financing rather than internal generation.
- High Volatility & Overextension Risk: With a beta of 2.05, the stock is more than twice as volatile as the market. Trading near its 52-week high after a 354% run-up, it is susceptible to sharp pullbacks, as seen in the recent 15.48% intraday decline from the previous close.
- Inconsistent Profitability & Thin Margins: While quarterly profits improved, the TTM net margin is a thin 0.85%, and ROE is a low 0.61%. Earnings have been volatile, swinging from losses to profits, indicating the business model's profitability is not yet stable or robust.
COHR Technical Analysis
The stock is in a powerful, sustained uptrend, evidenced by a staggering 354.56% gain over the past year. As of the latest close at $361.47, the price is trading near the top of its 52-week range, approximately 87% of the way from its 52-week low of $73.66 toward its high of $413.00, indicating strong momentum but also proximity to a key technical resistance level that could signal overextension. Recent momentum remains robust but shows signs of volatility; the stock is up 18.54% over the past month and 39.60% over the past three months, significantly outpacing the S&P 500's gains of 6.31% and 10.28%, respectively, as indicated by relative strength figures of 12.23 and 29.32. However, the 1-month gain is notably lower than the 3-month and 1-year figures, suggesting a potential deceleration or consolidation phase within the broader uptrend, which is corroborated by the stock's high beta of 2.05, implying it is more than twice as volatile as the market. Key technical levels are clearly defined, with immediate resistance at the 52-week high of $413.00 and support anchored by the 52-week low of $73.66, though more relevant near-term support may be found around recent pullback lows near $300. A decisive breakout above $413 would signal a continuation of the powerful bull trend, while a breakdown below key support could indicate a deeper correction. The stock's extreme volatility, quantified by a beta of 2.05, means it experiences amplified moves relative to the broader market, which is a critical consideration for risk management and position sizing, especially given the recent 15.48% intraday price decline from the previous close. The stock's high volatility is further illustrated by its significant price swings within the provided 180-day data, such as the surge from around $163 in early December 2025 to over $400 by mid-May 2026, followed by recent pullbacks. The Relative Strength Index (RSI) data is not explicitly provided, but the extreme price movements and high beta suggest the stock frequently enters overbought or oversold territory. Volume of 11.07 million shares indicates active trading interest, supporting the momentum narrative. The path of least resistance remains upward, but the high beta and proximity to the 52-week high warrant caution for new entries.
Beta
2.05
2.05x market volatility
Max Drawdown
-26.5%
Largest decline past year
52-Week Range
$77-$434
Price range past year
Annual Return
+456.0%
Cumulative gain past year
| Period | COHR Return | S&P 500 |
|---|---|---|
| 1m | +29.6% | +5.4% |
| 3m | +55.3% | +10.9% |
| 6m | +140.7% | +11.0% |
| 1y | +456.0% | +28.1% |
| ytd | +119.7% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
COHR Fundamental Analysis
Revenue growth has been strong and accelerating. For the quarter ending December 31, 2025, revenue was $1.686 billion, representing a 17.52% year-over-year increase. This marks a significant acceleration from the growth trajectory seen in prior quarters, such as Q1 2026 (Sept 2025) revenue of $1.581 billion and Q4 2025 (June 2025) revenue of $1.529 billion. Segment data shows the Lasers Segment contributed $711.9 million and the Materials Segment $472.9 million for an unspecified period, indicating both core business lines are substantial drivers. This accelerating top-line growth is central to the AI-driven investment thesis, suggesting the company is successfully capitalizing on demand for its optical components. Profitability has improved markedly but remains inconsistent on a quarterly basis. The most recent quarter shows net income of $147 million, gross margin of 36.95%, and operating margin of 11.80%. This represents a strong recovery from the net loss of -$95.6 million in Q4 2025 (June 2025). The trailing twelve-month net margin is a thin 0.85%, but the quarterly operating margin of 9.45% (from valuation data) and gross margin of 35.41% indicate the underlying business can generate healthy profits. The improvement from a net loss to substantial net income within two quarters signals a powerful turnaround in earnings, likely driven by revenue growth and operating leverage. The balance sheet appears reasonably healthy with a current ratio of 2.19 and a moderate debt-to-equity ratio of 0.48. Return on Equity (ROE) is a low 0.61%, and Return on Assets (ROA) is 3.14%, reflecting the company's recent journey back to profitability. A critical concern is free cash flow; the TTM free cash flow is negative $103.6 million, and the latest quarterly operating cash flow was a modest $57.9 million against capital expenditures, resulting in negative free cash flow. This indicates the company is consuming cash to fund its operations and growth, likely through working capital and capital expenditures, rather than generating surplus cash internally. The debt level is manageable, but the negative FCF suggests dependence on external financing or existing cash balances to sustain growth.
Quarterly Revenue
$1.7B
2025-12
Revenue YoY Growth
+0.17%
YoY Comparison
Gross Margin
+0.36%
Latest Quarter
Free Cash Flow
$-103617000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is COHR Overvalued?
Given the company's positive net income ($147 million in the latest quarter), the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE ratio is extremely high at 279.75x, reflecting the market's forward-looking optimism and the stock's massive price appreciation relative to recently recovered earnings. The forward PE is substantially lower at 44.65x, indicating the market expects significant earnings growth to normalize this multiple. The wide gap between trailing and forward PE underscores high growth expectations embedded in the current price. Compared to sector averages, the stock trades at a significant premium. Its trailing PE of 279.75x and forward PE of 44.65x are well above typical hardware industry averages, which often range in the teens to low-20s. The Price-to-Sales (PS) ratio of 2.38 and EV-to-Sales of 11.37 are also elevated. This substantial premium is likely justified by investors betting on Coherent's superior growth trajectory and strategic positioning within the AI infrastructure supply chain, as opposed to more mature hardware peers. The premium valuation implies that any disappointment in growth or margins could lead to a severe multiple contraction. Historically, the current valuation is near its peak. The historical ratios data shows the stock's own trailing PE has fluctuated wildly, from negative values during loss-making periods to 48.81x as of Q2 2026 (Dec 2025). The current trailing PE of 279.75x far exceeds recent historical levels, indicating the market is pricing in extremely optimistic future earnings growth. Similarly, the PS ratio of 2.38 is below the 17.02x recorded in the historical data for Q2 2026, but this discrepancy is due to the massive increase in market cap and revenue growth. Trading near its own historical valuation highs suggests expectations are fully priced in, leaving little room for error and increasing downside risk if execution falters.
PE
279.8x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -173x~520x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
15.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are significant. The company's negative TTM free cash flow of -$103.6M indicates it is burning cash to fund growth, creating reliance on external capital markets or cash reserves. While debt is moderate at a 0.48 D/E ratio, the thin TTM net margin of 0.85% and volatile quarterly earnings (from a -$95.6M loss to a $147M profit) show profitability is not yet durable. Revenue concentration in the cyclical semiconductor and industrial markets adds to earnings volatility, making the company vulnerable to any slowdown in AI infrastructure spending.
Market & Competitive Risks are elevated due to valuation. Trading at a forward P/E of 44.65x—a substantial premium to sector peers—COHR faces acute valuation compression risk if growth decelerates or macro conditions tighten. Its high beta of 2.05 confirms extreme sensitivity to broader market swings. Competitive disruption is a constant threat in the fast-evolving photonics industry, and the stock's 354% gain has likely pulled forward years of optimism, leaving it exposed to profit-taking and sector rotation, especially if interest rates rise as recent news suggests.
Worst-Case Scenario involves a 'growth scare' coinciding with a market downturn. A quarterly revenue miss or margin disappointment could shatter the high-growth narrative, triggering analyst downgrades and a rapid multiple contraction from 44.65x forward P/E toward the sector average. Combined with its high beta, this could catalyze a violent sell-off. The realistic downside could approach the 52-week low of $73.66, representing a potential loss of nearly -80% from the current price of $361.47. A more probable severe correction might target the $200-$250 range (a -30% to -45% decline), aligning with previous support levels from Q1 2026.
FAQ
The key risks are: 1) Valuation Risk: The extreme forward P/E of 44.65x creates high vulnerability to multiple contraction if growth slows. 2) Financial Quality Risk: Persistent negative free cash flow (-$103.6M TTM) indicates cash burn, not self-sustaining growth. 3) Volatility Risk: A beta of 2.05 means the stock will experience amplified swings, likely causing large portfolio drawdowns. 4) Execution & Cyclical Risk: The company operates in cyclical industrial and tech markets; a miss on quarterly revenue or margins could break the growth narrative and trigger a severe sell-off.
The 12-month forecast is highly bifurcated, with a high degree of uncertainty reflected in the stock's high beta. The base case (50% probability) sees the stock trading between $300 and $380 as it digests its massive gains and growth meets high expectations. The bull case (25% probability) targets $413 to $500 on breakout earnings and multiple expansion. The bear case (25% probability) warns of a correction to $200-$280 on a growth scare or macro downturn. The most likely scenario is the base case, which assumes the company executes well but the valuation remains a ceiling on near-term upside.
COHR is significantly overvalued based on traditional metrics. Its trailing P/E of 279.75x and forward P/E of 44.65x command a massive premium over the typical hardware sector. The Price-to-Sales ratio of 2.38 and EV-to-Sales of 11.37 are also elevated. This valuation implies the market expects years of superior growth and margin expansion tied to the AI boom. It is trading near its own historical valuation peaks, leaving little margin for error. The stock is priced for perfection, making it vulnerable to a sharp derating if execution falters.
COHR is a high-risk, high-potential-reward stock that is not a good buy for most investors at its current price of $361.47. While the AI growth story is powerful and revenue is accelerating at 17.52% YoY, the valuation is extreme with a forward P/E of 44.65x, and the stock has already risen 354% in a year. It could be a good buy for very aggressive, risk-tolerant investors who are willing to stomach the high beta of 2.05, but only on a significant pullback that improves the risk/reward, such as a move toward the $300 support level.
COHR is unsuitable for short-term trading due to its extreme volatility (beta 2.05) and lack of a dividend. It is theoretically a long-term investment for those believing in the multi-year AI infrastructure theme, but the current valuation makes even a long-term hold risky, as much of that future growth is already priced in. Given the need for the company to prove it can generate sustainable profits and cash flow, a minimum holding period of 3-5 years is required to see if the narrative plays out. However, investors entering now must be prepared for a potentially rocky journey with significant drawdowns along the way.